GlobeImmune, which is developing therapeutic drugs for pancreatic cancer and hepatitis B and C, withdrew its plans for an initial public offering on Thursday citing poor market conditions. The Louisville, CO-based company was founded in 1995 and last updated its filing on September 5, 2012.
Help employers find you! Check out all the jobs and post your resume.
